Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Adenosine monophosphate function

Serotoninergic System. Figure 1 Graphical representation of the current classification of 5-hydroxytryptamine (5-HT) receptors. Receptor subtypes represented by shaded boxes and lowercase designate receptors that have not been demonstrated to definitively function in native systems. Abbreviations 3-5r cyclic adenosine monophosphate (cAMP) phospholipase C (PLC) negative (-ve) positive (+ve)... [Pg.1123]

The most common second messenger activated by protein/peptide hormones and catecholamines is cyclic adenosine monophosphate (cAMP). The pathway by which cAMP is formed and alters cellular function is illustrated in Figure 10.1. The process begins when the hormone binds to its receptor. These receptors are quite large and span the plasma membrane. On the cytoplasmic surface of the membrane, the receptor is associated with a G protein that serves as the transducer molecule. In other words, the G protein acts as an intermediary between the receptor and the second messengers that will alter cellular activity. These proteins are referred to as G proteins because they bind with guanosine nucleotides. In an unstimulated cell, the inactive G protein binds guanosine diphosphate (GDP). When the hormone... [Pg.116]

Abnormal G protein functioning dysregulates adenylate cyclase activity, phosphoinositide responses, sodiurrypotassiunVcalcium channel exchange, and activity of phospholipases. Abnormal cyclic adenosine monophosphate and phosphoinositide secondary messenger system activity. [Pg.771]

TTie second messenger, for example cyclic adenosine monophosphate (cAMP), then activates cAMP-dependent protein kinase which modulates the function of a broad range of membrane receptors, intracellular enzymes, ion channels and transcription factors. [Pg.27]

Another drug that has been found to have anticytokine activity is pentoxifylline. It was initially characterized as a haemorheologic agent for the treatment of peripheral vascular diseases [141]. In addition, it was also found to be capable of inhibiting the pro-inflammatory actions of IL-1 and TNEa on neutrophil function and cytokine production by monocytic cells [142]. Its mechanism of action is the inhibition of phosphodiesterases, leading to increased intracellular levels of cyclic adenosine monophosphate [143]. Besides its effects on the cytokine network, pentoxifylline also exerted an anti-fibrogenic action in cultures of fibroblasts and in animal models of fibrosis [144] and could therefore be an attractive candidate for targeting hepatic inflammation. [Pg.105]

The Hi Receptor and its Ligands. The H receptor mediates effects, through an increase in cyclic adenosine monophosphate (cAMP). such as gastric acid secretion relaxation of airway smooth muscle and of pulmonary vessels increased lower airway mucus secretion esophageal contraclion inhibition of basophil, but not mas cell histamine release inhibition of neutrophil activation and induction or suppressor T cells. There is no evidence that the H- receptor causes significant modulation of lung function in the healthy human subject or in the asthmatic. [Pg.777]

Histamine stimulation of parietal cell function by increasing the formation of cyclic adenosine monophosphate (cyclic AMP)... [Pg.592]

A frequently cited mechanism of action for these agents is phosphodiesterase (PDE) inhibition and the associated antiplatelet effects that accompany increases in intracellular cyclic adenosine monophosphate (cAMP). In fact, the effects of these drugs go far beyond their direct effect on PDE inhibition or platelet function. This chapter discusses (/) cyclic nucleotides, PDE, and PDE inhibitors (if) the mechanisms of action of dipyridamole and cilostazol (Hi) drug issues and (iv) current clinical applications for dipyridamole and cilostazol, including recent clinical trials that may have changed our perception of the possible utility of these agents for percutaneous intervention. [Pg.69]

Adenylyl cyclase is the effector enzyme that synthesizes cyclic adenosine monophosphate (cAMP) from ATP. Cyclic AMP functions as a second messenger to relay extracellular signals to intracellular enzymes such as protein kinase A. Adenylyl cyclases are integral membrane proteins that... [Pg.146]


See other pages where Adenosine monophosphate function is mentioned: [Pg.254]    [Pg.191]    [Pg.1274]    [Pg.34]    [Pg.86]    [Pg.3]    [Pg.246]    [Pg.183]    [Pg.77]    [Pg.233]    [Pg.308]    [Pg.194]    [Pg.81]    [Pg.190]    [Pg.192]    [Pg.307]    [Pg.309]    [Pg.354]    [Pg.747]    [Pg.593]    [Pg.116]    [Pg.148]    [Pg.93]    [Pg.254]    [Pg.517]    [Pg.1027]    [Pg.190]    [Pg.348]    [Pg.304]    [Pg.354]    [Pg.516]    [Pg.814]    [Pg.226]    [Pg.549]    [Pg.600]    [Pg.491]    [Pg.163]    [Pg.35]    [Pg.26]   
See also in sourсe #XX -- [ Pg.156 , Pg.157 , Pg.158 , Pg.159 , Pg.160 , Pg.161 , Pg.162 , Pg.163 , Pg.163 , Pg.164 , Pg.165 , Pg.166 , Pg.167 , Pg.168 , Pg.169 , Pg.170 ]




SEARCH



Adenosine 5 monophosphate

Cyclic adenosine monophosphate second messenger function

© 2024 chempedia.info